Go Ad-Free
    My Alerts
    Moneycontrol
    Moneycontrol PRO
    Loans
    Loans
    HomeNewsClinical trials

    Clinical Trials

    Jump to

    • Syngene: Is the worst of worries priced in?

      The company is working on growth levers, such as expanding biologics manufacturing in Bengaluru, investing in clinical capabilities for peptides, and foraying into clinical trials opportunity.

    • Ask ChatGPT if you are eligible for a clinical trial: It may help speed up the screening process, study finds

      Researchers used GPT-3.5 and GPT-4, trying three ways to guide the model. The most effective version, GPT-4, gave more accurate results but took slightly more time and cost.

    • Wockhardt hopes to complete Phase III trials for Zaynich by Q1 of 2025

      So far it has supplied the compound to 30 patients for compassionate use with range of life-threatening infections

    • Regulatory nod for conducting clinical trials of Colchicine on COVID-19 patients: CSIR

      Ram Vishwakarma, the advisor to the CSIR Director General, said Colchicine in combination with standard care will be an important therapeutic intervention for COVID-19 patients with cardiac co-morbidities and also for reducing pro-inflammatory cytokines, leading to faster recovery.

    • COVID-19 | DRDO’s 2-DG drug, touted as “affordable”, has final price tag of Rs 990

      At Rs 990/sachet, the final outcome seems far from what was promised in an official statement in May, when the company said price would be determined “with a view to making it accessible and affordable to as many patients as possible".

    • Clinical Trials Are Moving Out of the Lab and Into People’s Homes

      According to one analysis, nearly 6,000 trials registered on ClinicalTrials.gov were stopped between Jan. 1 and May 31, roughly twice as many compared with non-pandemic times.

    • Coronavirus pandemic | India mulls relaxing clinical trial rules to develop COVID-19 vaccine

      Right now, Serum Institute of India and Cadila Healthcare are trying to develop a COVID-19 vaccine. Although they are in the pre-clinical stage, human trials will be conducted eventually.

    • DCGI to put clinical trials of Malpani Hospital under scanner

      The decision comes in the wake of the drug regulator finding certain discrepancies at the clinical trial site linked to a phase two clinical trial of Glenmark’s osteoarthritis pain drug.

    • Health ministry planning to scrap clinical trials for proven drugs to fast-track market availability

      The set of rules, tabled by the Union health ministry, also recommended doing away with local clinical trials for drugs which have a record of not affecting patients severely, according to Mint.

    • Govt to unveil new clinical trial policy soon; single clearance, transparency key features

      The new policy expected to be unveiled in a month includes single clearance for clinical trials and is more transparent.

    • REAN Cloud Celebrates Healthcare & Pharma Enterprise Modernization Week

      REAN Cloud (“REAN”), a

    • H2FY14 unlikely to be as robust as H1: Suven Life Sciences

      Speaking to CNBC-TV18, Venkat Jasti, chairman and chief executive officer, Suven Life Sciences, says the company expects three compounds to go into phase I in FY15 and lower research and development expenses in H2FY14 vis a vis H1FY14.

    • Merck drops India from Priority market list

      US pharma major Merck (MSD) dropped India from its list of priority markets. Other top multinational pharma companies have also sounded warning bells about India's IPR regime.

    • Swati Piramal on how India can lead in low-cost health care

      Bad regulations and price control are stifling pharma, but innovation in health care is blossoming with government support

    • Indian pharma cos shift R&D to SE Asian countries: Assocham

      "Various South-East Asian countries namely Cambodia, Korea, the Philippines, Singapore, Thailand, Vietnam and others are wooing India's R&D industry by offering sops and transparent regulations," the survey said.

    • Govt set to notify rules for clinical trials

      After over 2,242 deaths during clinical drug trials in last five years, the government plans to regulate the USD 500 million sector by bringing changes in drug laws, to make lapses by pharma MNCs a punishable offence and enhance compensation among other steps.

    • No proof of GVK drug trials going awry: DL Reddy

      Andhra Pradesh health minister DL Ravindra Reddy said that there is no evidence to prove the participation of GVK Bio Sciences and the investigations are being carried on to punish the guilty.

    Advisory Alert: It has come to our attention that certain individuals are representing themselves as affiliates of Moneycontrol and soliciting funds on the false promise of assured returns on their investments. We wish to reiterate that Moneycontrol does not solicit funds from investors and neither does it promise any assured returns. In case you are approached by anyone making such claims, please write to us at grievanceofficer@nw18.com or call on 02268882347